[
    [
        {
            "time": "",
            "original_text": "益方生物科创板上会在即：核心产品商业化待成型 “大方”斥资8亿用于股权激励",
            "features": {
                "keywords": [
                    "益方生物",
                    "科创板",
                    "上会",
                    "核心产品",
                    "商业化",
                    "股权激励"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "益方生物科创板上会在即：核心产品商业化待成型 “大方”斥资8亿用于股权激励",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]